Clement Gauvain

Boulevard Du Pr Jules Leclercq
Lille, 59000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Pembrolizumab versus pembrolizumab plus chemotherapy in patients with PDL1 ⩾50% advanced non-small-cell lung cancer, depending on tumor aggressiveness and clinical impact.

Pembrolizumab versus pembrolizumab plus chemotherapy in patients with PDL1 ⩾50% advanced non-small-cell lung cancer, depending on tumor aggressiveness and clinical impact.

Journal: Therapeutic advances in medical oncology

Published: August 13, 2025

Impact of corticosteroids on the efficacy of first-line pembrolizumab plus chemotherapy in patients with advanced non-small-cell lung cancer.

Impact of corticosteroids on the efficacy of first-line pembrolizumab plus chemotherapy in patients with advanced non-small-cell lung cancer.

Journal: Therapeutic advances in medical oncology

Published: September 20, 2024

Histo-Molecular Factors of Response to Combined Chemotherapy and Immunotherapy in Non-Small Cell Lung Cancers.

Histo-Molecular Factors of Response to Combined Chemotherapy and Immunotherapy in Non-Small Cell Lung Cancers.

Journal: Targeted oncology

Published: October 11, 2023

Characterization of 164 patients with NRAS mutated non-small cell lung cancer (NSCLC).

Characterization of 164 patients with NRAS mutated non-small cell lung cancer (NSCLC).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: July 16, 2023

Pursuit or discontinuation of anti-PD1 after 2 years of treatment in long-term responder patients with non-small cell lung cancer.

Pursuit or discontinuation of anti-PD1 after 2 years of treatment in long-term responder patients with non-small cell lung cancer.

Journal: Therapeutic advances in medical oncology

Published: March 04, 2023

Immune-Checkpoint Inhibitors for Malignant Pleural Mesothelioma: A French, Multicenter, Retrospective Real-World Study.

Immune-Checkpoint Inhibitors for Malignant Pleural Mesothelioma: A French, Multicenter, Retrospective Real-World Study.

Journal: Cancers

Published: February 22, 2022

Interstitial lung diseases associated with mutations of poly(A)-specific ribonuclease: A multicentre retrospective study.

Interstitial lung diseases associated with mutations of poly(A)-specific ribonuclease: A multicentre retrospective study.

Journal: Respirology (Carlton, Vic.)

Published: September 04, 2021

Determinants of survival after lung transplantation in telomerase-related gene mutation carriers: A retrospective cohort.

Determinants of survival after lung transplantation in telomerase-related gene mutation carriers: A retrospective cohort.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: March 03, 2021

Salvage Immunotherapy With Pembrolizumab in Patients Hospitalized for Life-Threatening Complications of NSCLC.

Salvage Immunotherapy With Pembrolizumab in Patients Hospitalized for Life-Threatening Complications of NSCLC.

Journal: JTO clinical and research reports

Published: July 16, 2020

Correction: Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome.

Correction: Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome.

Journal: The Journal of experimental medicine

Published: June 10, 2020

Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome.

Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome.

Journal: The Journal of experimental medicine

Published: September 25, 2019

Erratum to "Intracerebral efficacy and tolerance of nivolumab in non-small-cell lung cancer patients with brain metastases" [Lung Cancer 116 (February 2018) 62-66].

Erratum to "Intracerebral efficacy and tolerance of nivolumab in non-small-cell lung cancer patients with brain metastases" [Lung Cancer 116 (February 2018) 62-66].

Journal: Lung cancer (Amsterdam, Netherlands)

Published: August 19, 2019

Showing 1-12 of 18

Last Updated: 09/26/2026